Clinical Trial Update: A Trial of Solriamfetol in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating solriamfetol for chronic fatigue syndrome/myalgic encephalomyelitis has completed; sponsor is Rochester Center for Behavioral …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue Syndrome
• Myalgic Encephalomyelitis

Drugs mentioned

• Sunosi (solriamfetol)

Snippet

Sponsor: Rochester Center for Behavioral Medicine | Conditions: Chronic Fatigue Syndrome, Myalgic Encephalomyelitis | Phase 4 | Status: COMPLETED